Cargando…

Improved use of faecal immunochemical tests for haemoglobin in the Scottish bowel screening programme

OBJECTIVES: This study aimed to develop a risk-scoring model in the Scottish Bowel Screening Programme incorporating faecal haemoglobin concentration with other risk factors for colorectal cancer. METHODS: Data were collected for all individuals invited to participate in the Scottish Bowel Screening...

Descripción completa

Detalles Bibliográficos
Autores principales: Digby, Jayne, Fraser, Callum G, Clark, Gavin, Mowat, Craig, Strachan, Judith A, Steele, Robert JC
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629250/
https://www.ncbi.nlm.nih.gov/pubmed/37229658
http://dx.doi.org/10.1177/09691413231175611
_version_ 1785131927404019712
author Digby, Jayne
Fraser, Callum G
Clark, Gavin
Mowat, Craig
Strachan, Judith A
Steele, Robert JC
author_facet Digby, Jayne
Fraser, Callum G
Clark, Gavin
Mowat, Craig
Strachan, Judith A
Steele, Robert JC
author_sort Digby, Jayne
collection PubMed
description OBJECTIVES: This study aimed to develop a risk-scoring model in the Scottish Bowel Screening Programme incorporating faecal haemoglobin concentration with other risk factors for colorectal cancer. METHODS: Data were collected for all individuals invited to participate in the Scottish Bowel Screening Programme between November 2017 and March 2018 including faecal haemoglobin concentration, age, sex, National Health Service Board, socioeconomic status, and screening history. Linkage with The Scottish Cancer Registry identified all screening participants diagnosed with colorectal cancer. Logistic regression was performed to identify which factors demonstrated significant association with colorectal cancer and could be used in the development of a risk-scoring model. RESULTS: Of 232,076 screening participants, 427 had colorectal cancer: 286 diagnosed following a screening colonoscopy and 141 arising after a negative screening test result giving an interval cancer proportion of 33.0%. Only faecal haemoglobin concentration and age showed a statistically significant association with colorectal cancer. Interval cancer proportion increased with age and was higher in women (38.1%) than men (27.5%). If positivity in women were mirrored in men at each age quintile interval cancer proportion would still have remained higher in women (33.2%). Moreover, an additional 1201 colonoscopies would be required to detect 11 colorectal cancers. CONCLUSIONS: Development of a risk scoring model using early data from the Scottish Bowel Screening Programme was not feasible due to most variables showing insignificant association with colorectal cancer. Tailoring the faecal haemoglobin concentration threshold according to age could help to diminish some of the disparity in interval cancer proportion between women and men. Strategies to achieve sex equality using faecal haemoglobin concentration thresholds depend considerably on which variable is selected for equivalency and this requires further exploration.
format Online
Article
Text
id pubmed-10629250
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-106292502023-11-08 Improved use of faecal immunochemical tests for haemoglobin in the Scottish bowel screening programme Digby, Jayne Fraser, Callum G Clark, Gavin Mowat, Craig Strachan, Judith A Steele, Robert JC J Med Screen Original Articles OBJECTIVES: This study aimed to develop a risk-scoring model in the Scottish Bowel Screening Programme incorporating faecal haemoglobin concentration with other risk factors for colorectal cancer. METHODS: Data were collected for all individuals invited to participate in the Scottish Bowel Screening Programme between November 2017 and March 2018 including faecal haemoglobin concentration, age, sex, National Health Service Board, socioeconomic status, and screening history. Linkage with The Scottish Cancer Registry identified all screening participants diagnosed with colorectal cancer. Logistic regression was performed to identify which factors demonstrated significant association with colorectal cancer and could be used in the development of a risk-scoring model. RESULTS: Of 232,076 screening participants, 427 had colorectal cancer: 286 diagnosed following a screening colonoscopy and 141 arising after a negative screening test result giving an interval cancer proportion of 33.0%. Only faecal haemoglobin concentration and age showed a statistically significant association with colorectal cancer. Interval cancer proportion increased with age and was higher in women (38.1%) than men (27.5%). If positivity in women were mirrored in men at each age quintile interval cancer proportion would still have remained higher in women (33.2%). Moreover, an additional 1201 colonoscopies would be required to detect 11 colorectal cancers. CONCLUSIONS: Development of a risk scoring model using early data from the Scottish Bowel Screening Programme was not feasible due to most variables showing insignificant association with colorectal cancer. Tailoring the faecal haemoglobin concentration threshold according to age could help to diminish some of the disparity in interval cancer proportion between women and men. Strategies to achieve sex equality using faecal haemoglobin concentration thresholds depend considerably on which variable is selected for equivalency and this requires further exploration. SAGE Publications 2023-05-25 2023-12 /pmc/articles/PMC10629250/ /pubmed/37229658 http://dx.doi.org/10.1177/09691413231175611 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Articles
Digby, Jayne
Fraser, Callum G
Clark, Gavin
Mowat, Craig
Strachan, Judith A
Steele, Robert JC
Improved use of faecal immunochemical tests for haemoglobin in the Scottish bowel screening programme
title Improved use of faecal immunochemical tests for haemoglobin in the Scottish bowel screening programme
title_full Improved use of faecal immunochemical tests for haemoglobin in the Scottish bowel screening programme
title_fullStr Improved use of faecal immunochemical tests for haemoglobin in the Scottish bowel screening programme
title_full_unstemmed Improved use of faecal immunochemical tests for haemoglobin in the Scottish bowel screening programme
title_short Improved use of faecal immunochemical tests for haemoglobin in the Scottish bowel screening programme
title_sort improved use of faecal immunochemical tests for haemoglobin in the scottish bowel screening programme
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629250/
https://www.ncbi.nlm.nih.gov/pubmed/37229658
http://dx.doi.org/10.1177/09691413231175611
work_keys_str_mv AT digbyjayne improveduseoffaecalimmunochemicaltestsforhaemoglobininthescottishbowelscreeningprogramme
AT frasercallumg improveduseoffaecalimmunochemicaltestsforhaemoglobininthescottishbowelscreeningprogramme
AT clarkgavin improveduseoffaecalimmunochemicaltestsforhaemoglobininthescottishbowelscreeningprogramme
AT mowatcraig improveduseoffaecalimmunochemicaltestsforhaemoglobininthescottishbowelscreeningprogramme
AT strachanjuditha improveduseoffaecalimmunochemicaltestsforhaemoglobininthescottishbowelscreeningprogramme
AT steelerobertjc improveduseoffaecalimmunochemicaltestsforhaemoglobininthescottishbowelscreeningprogramme